SpineGuard H1 FY26 net loss widens to EUR 1.23 million; revenue drops 32% to EUR 1.45 million

• SpineGuard H1 revenue fell 32% to EUR 1.45 million; operating loss widened to EUR 1.18 million.
• Net loss widened 13.21% to EUR 1.23 million; gross margin rate dropped 17.2 percentage points to 61.3%.
• US revenue slid 47% to USD 776,000 on the shift from direct sales to a distribution model with Omnia Medical.
• DSG units sold declined 17% to 2,544; cash and liquid investments decreased to EUR 694,000 from EUR 1.72 million.
• Management reiterated a target for operational breakeven in Q4 2026; financing runway seen through Q2 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SpineGuard SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202609091200BIZWIRE_USPR_____20260909_BW085346) on September 09, 2026, and is solely responsible for the information contained therein.